🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Recent prospective multicenter phase II study assessed the efficacy and tol...
Status
Unknown
Location
Kosin University Gospel Hospital
Start Date
2019-03-11
Trial ID
NCT03809780
Treatments Being Tested
This study aims to implement two interventions to determine the most effect...
Status
Not Yet Recruiting
Location
Danfa Community
Start Date
2026-10-01
Trial ID
NCT07745517
This study is a prospective cohort clinical trial that aims to investigate ...
Status
Recruiting
Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Start Date
2023-01-16
Trial ID
NCT05872724
Irritable Bowel Syndrome with diarrhoea (IBS-D) is a functional gastrointes...
Status
Completed
Location
MHAT "Haskovo", Second Internal Department
Start Date
2010-10
Trial ID
NCT01303224
The purpose of this protocol is to provide compassionate use of Kedrion Hum...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04586062
Treatments Being Tested
The objective of the observational study "UP-GRADE: Assessment of Psychopat...
Status
Completed
Location
Fondazione IRCCS Policlinico San Matteo, SC Pediatria
Start Date
2023-09-12
Trial ID
NCT07375784
Treatments Being Tested
Evaluation of fractional flow reserve (FFR) is a key method for assessing i...
Status
Unknown
Location
CHU Besancon
Start Date
2021-05-19
Trial ID
NCT04818918
Treatments Being Tested
The studies described in this protocol are all performed within the framewo...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01587833
Treatments Being Tested
This randomized controlled study aimed to evaluate the effect of Metaverse-...
Status
Completed
Location
Bursa, Nilufer, 16059
Start Date
2023-07-01
Trial ID
NCT07078825
The purpose of this phase III study is to determine whether Doxorubicin Tra...
Status
Completed
Location
Gabrail Cancer Center
Start Date
2012-06
Trial ID
NCT01655693
Treatments Being Tested